Persistent high level of fibroblast growth factor 23 as a cause of post-renal transplant hypophosphatemia

被引：7

作者：

Kawarazaki H. ^{[1
]}

Shibagaki Y. ^{[1
]}

Shimizu H. ^{[1
]}

Kawarazaki W. ^{[1
]}

Ito N. ^{[1
]}

Ishikawa A. ^{[2
]}

Fukumoto S. ^{[1
]}

Fujita T. ^{[1
]}

机构：

[1] Department of Nephrology and Endocrinology, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-8655

[2] Department of Urology, Graduate School of Medicine, University of Tokyo, Tokyo

来源：

Clinical and Experimental Nephrology | 2007年 / 11卷 / 3期

关键词：

Fibroblast growth factor 23; Hypophosphatemia; Kidney transplantation; Parathyroid hormone; Phosphaturia; Vitamin D;

D O I：

10.1007/s10157-007-0489-0

中图分类号：

学科分类号：

摘要：

Post-transplant hypophosphatemia is a highly prevalent problem, and fibroblast growth factor 23, a newly discovered phosphatonin, has recently been reported to be involved in its pathogenesis. We report a 52-year-old Japanese woman who received a living-related kidney transplant and showed severe hypophosphatemia immediately after transplantation. We suspected that fibroblast growth factor 23 was the main cause of this hypophosphatemia and investigated its levels longitudinally after the transplantation. The patient showed persistently high levels of fibroblast growth factor 23, with suppressed 1,25-dihydroxyvitamin D and parathyroid hormone. She recovered from the hypophosphatemia when fibroblast growth factor returned to its reference level half a year after the transplantation. We conclude that a persistently high level of fibroblast growth factor 23 is an important cause of post-transplant hypophosphatemia, other than hyperparathyroidism, a previously noted cause. © 2007 Japanese Society of Nephrology.

引用

页码：255 / 257

页数：2

共 10 条

[1]

Levi M., Post-transplant hypophosphatemia, Kidney Int, 59, pp. 2377-87, (2001)

[2]

Ghanekar H., Welch B.J., Moe O.W., Sakhae K., Post-renal transplantation hypophosphatemia: A review and novel insights, Curr Opin Nephrol Hypertens, 15, pp. 97-104, (2006)

[3]

Green J., Debby H., Lederer E., Levi M., Zajicek H.K., Bick T., Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturia, Kidney Int, 60, pp. 1182-96, (2001)

[4]

Bhan I., Shah A., Holmes J., Isakova T., Gutierrez O., Burnett S.A., Et al., Post-transplant hypophosphatemia: Tertiary "hyperphosphatoninism, Kidney Int, 70, pp. 1486-94, (2006)

[5]

Pande S., Ritter C.S., Rothstein M., Wiesen K., Vassiliadis J., Kumor R., Et al., FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation, Nephron Physiol, 104, pp. 23-32, (2006)

[6]

Messa P., Sindici C., Cannella G., Miotti V., Risaliti A., Gropuzzo M., Et al., Persistent secondary hyperparathyroidism after renal transplantation, Kidney Int, 54, pp. 1704-13, (1998)

[7]

Evenepoel P., Naesens M., Claes K., Kuypers D., Vanrenterghem Y., Tertiary "hyperphosphatoninism" accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients, Am J Transplant, 7, pp. 1-8, (2007)

[8]

Yamazaki Y., Okazaki R., Shibata M., Hasegawa Y., Satoh K., Tajima T., Et al., Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia, J Clin Endocrinol Metab, 87, pp. 4957-60, (2002)

[9]

Berndt T.J., Schiavi S., Kumar R., phosphatonins" and the regulation of phosphorus homeostasis, Am J Physiol Renal Physiol, 289, pp. 1170-82, (2005)

[10]

Fukumoto S., Yamashita T., FGF23 is a hormone regulating phosphate metabolism-unique biological characteristics of FGF23, Bone, 40, pp. 1190-5, (2007)

← 1 →